Sequent Scientific Limited — Board Meeting, 20-05-2025: Outcome of Board Meeting

Sequent Scientific has announced a board meeting on May 20, 2025, approving the audited consolidated financial results for FY25. The company posted revenue of ₹1,551.37 Cr and a profit after tax of ₹10.65 Cr, recovering from losses last year. Exceptional costs included ₹5.26 Cr related to a proposed merger and a ₹4 Cr one-time settlement by subsidiary Alivira. No dividend was declared to preserve cash. The Board also approved appointing BMP & Co LLP as Secretarial Auditors for five years, pending shareholder nod.